Nanoformulations in Pharmaceutical and Biomedical Applications: Green Perspectives.

Since the first globally marketed nanomedicines approved by the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA), the number of marketed nanopharmaceuticals showed an increasing trend [ 18 ].

also in 63,971 other papers